Category: Proteins & Peptides

Filter By
Brand: Biosensis Brand: Leinco Categories: Peptides Clear all
PARC Blocking Peptide - 50 µg PARC Blocking Peptide - 50 µg

PARC Blocking Peptide - 50 µg

Reference: P226-50 µg
€0.00 (tax incl.)
PARC peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
Lano Blocking Peptide - 50 µg Lano Blocking Peptide - 50 µg

Lano Blocking Peptide - 50 µg

Reference: L177-50 µg
€0.00 (tax incl.)
Lano peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
IL-27 (Intermediate Domain) Blocking Peptide - 50 µg IL-27 (Intermediate Domain) Blocking Peptide - 50 µg

IL-27 (Intermediate Domain) Blocking Peptide - 50 µg

Reference: I-512-50 µg
€0.00 (tax incl.)
Interleukin-27 (IL-27) is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.1 IL-27 is produced by...
IL-27 (NT) Blocking Peptide - 50 µg IL-27 (NT) Blocking Peptide - 50 µg

IL-27 (NT) Blocking Peptide - 50 µg

Reference: I-513-50 µg
€0.00 (tax incl.)
Interleukin-27 (IL-27) is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.1 IL-27 is produced by...
IL-31 (Intermediate Domain) Blocking Peptide - 50 µg IL-31 (Intermediate Domain) Blocking Peptide - 50 µg

IL-31 (Intermediate Domain) Blocking Peptide - 50 µg

Reference: I-514-50 µg
€0.00 (tax incl.)
Interleukin-31 (IL-31) is a T-cell cytokine, which is preferentially produced by type 2 helper T cells. The structure of IL-31 places it in the IL-6 family of cytokines. IL-31 signals via a receptor complex that is...
IL-31 (NT) Blocking Peptide - 50 µg IL-31 (NT) Blocking Peptide - 50 µg

IL-31 (NT) Blocking Peptide - 50 µg

Reference: I-515-50 µg
€0.00 (tax incl.)
Interleukin-31 (IL-31) is a T-cell cytokine, which is preferentially produced by type 2 helper T cells. The structure of IL-31 places it in the IL-6 family of cytokines. IL-31 signals via a receptor complex that is...
IRF3 (CT) Blocking Peptide - 50 µg IRF3 (CT) Blocking Peptide - 50 µg

IRF3 (CT) Blocking Peptide - 50 µg

Reference: I-518-50 µg
€0.00 (tax incl.)
IRF3 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
IRF8 Blocking Peptide - 50 µg IRF8 Blocking Peptide - 50 µg

IRF8 Blocking Peptide - 50 µg

Reference: I-520-50 µg
€0.00 (tax incl.)
IRF8 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
TIM-4 (CT) Blocking Peptide - 50 µg TIM-4 (CT) Blocking Peptide - 50 µg

TIM-4 (CT) Blocking Peptide - 50 µg

Reference: T350-50 µg
€0.00 (tax incl.)
TIM4 peptide is known as T cell immunoglobulin and mucin domain containing protein-4 and is a control peptide for blocking antibody binding in Western blotting.
TIM-4 (Intermediate Domain) Blocking Peptide - 50 µg TIM-4 (Intermediate Domain) Blocking Peptide - 50 µg

TIM-4 (Intermediate Domain) Blocking Peptide - 50 µg

Reference: T351-50 µg
€0.00 (tax incl.)
TIM-4 peptide is know as T Cell Immunoglobulin and Mucin Domain Containing Protein 4 and is applicable as a control peptide for blocking antibody binding in Western blotting.
ECSIT Blocking Peptide - 50 µg ECSIT Blocking Peptide - 50 µg

ECSIT Blocking Peptide - 50 µg

Reference: E185-50 µg
€0.00 (tax incl.)
ECSIT peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
SIGIRR (CT) Blocking Peptide - 50 µg SIGIRR (CT) Blocking Peptide - 50 µg

SIGIRR (CT) Blocking Peptide - 50 µg

Reference: S559-50 µg
€0.00 (tax incl.)
Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain, also known as SIGIRR is a member of the IL-1 receptor family.1 It acts as a negative regulator of interleukin (IL)-1 and lipopolysaccharide (LPS)...
ST2 (NT) Blocking Peptide - 50 µg ST2 (NT) Blocking Peptide - 50 µg

ST2 (NT) Blocking Peptide - 50 µg

Reference: S560-50 µg
€0.00 (tax incl.)
ST2 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
PKR (CT) Blocking Peptide - 50 µg PKR (CT) Blocking Peptide - 50 µg

PKR (CT) Blocking Peptide - 50 µg

Reference: P230-50 µg
€0.00 (tax incl.)
PKR peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
PKR (NT) Blocking Peptide - 50 µg PKR (NT) Blocking Peptide - 50 µg

PKR (NT) Blocking Peptide - 50 µg

Reference: P231-50 µg
€0.00 (tax incl.)
PKR peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
TAB1 Blocking Peptide - 50 µg TAB1 Blocking Peptide - 50 µg

TAB1 Blocking Peptide - 50 µg

Reference: T362-50 µg
€0.00 (tax incl.)
TAB1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
MD-1 (CT) Blocking Peptide - 50 µg MD-1 (CT) Blocking Peptide - 50 µg

MD-1 (CT) Blocking Peptide - 50 µg

Reference: M1222-50 µg
€0.00 (tax incl.)
MD-1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
Recombinant Human Myostatin Propeptide - 500 µg Recombinant Human Myostatin Propeptide - 500 µg

Recombinant Human Myostatin Propeptide - 500 µg

Reference: M1107-500 µg
€0.00 (tax incl.)
Myostatin propeptide (MRPO) has a very high binding affinity to myostatin and is a natural inhibitor of myostatin. MPRO is considered an attractive strategy for the treatment of muscle-wasting diseases such as...
Recombinant Human Myostatin Propeptide - 1 mg Recombinant Human Myostatin Propeptide - 1 mg

Recombinant Human Myostatin Propeptide - 1 mg

Reference: M1107-1 mg
€0.00 (tax incl.)
Myostatin propeptide (MRPO) has a very high binding affinity to myostatin and is a natural inhibitor of myostatin. MPRO is considered an attractive strategy for the treatment of muscle-wasting diseases such as...
Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg

Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg

Reference: PE-1749-50
€0.00 (tax incl.)
Synthetic beta-amyloid Aβ1-42 was monomerized by HFIP (hexafluoro-2-propanol) treatment and dried. One vial contains 50 μg monomeric Aβ peptide that can be used to form solutions of unaggregated Aβ monomers,...
Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng

Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng

Reference: PE-1750-1000
€0.00 (tax incl.)
A proprietary preparation of human amyloid beta peptide (amino acids 1-42) that was initially monomerized by HFIP-treatment and then allowed to form oligomers by the procedure described in Youmans KL et al., 2012,...

Menu

Settings

Please sign in first.

Sign in